Medical Software Company Agrees to Pay $500,000 to Resolve Allegations of Causing Medically Unnecessary Breast Cancer Screening Claims
BOSTON – PenRad Technologies, Inc. (PenRad), a software company headquartered in Raleigh, N.C., has agreed to pay $529,069 to resolve allegations that it violated the False Claims Act by causing health care providers to bill Medicare and MassHealth for medically unnecessary breast cancer screenings.
Action Details
- Date:December 15, 2025
- Agency:U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions